Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3042]
News [6143]
Articles [120]
Editorials [18]
Conferences [181]
elearning [32]
Post-HSCT management of ALL - Adult ALL perspective
Dr Josep Ribera - Catalan Institute of Oncology, Barcelona, Spain
Post-HSCT management of ALL - Adult ALL perspective ( Dr Josep Ribera - Catalan Institute of Oncology, Barcelona, Spain )
6 Dec 2021
Latest in diagnostics in EGFR mutated NSCLC
Dr Neal Lindeman - Brigham and Women's Hospital, Boston, USA
Latest in diagnostics in EGFR mutated NSCLC ( Dr Neal Lindeman - Brigham and Women's Hospital, Boston, USA )
3 Dec 2021
Cancer drug policy and access in LMICs
Dr Bishal Gyawali - Queen's University, Kingston, Canada
Cancer drug policy and access in LMICs ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
26 Nov 2021
Paediatric ALL perspective
Prof Andrea Biondi - University of Milano-Bicocca, Milan, Italy
Paediatric ALL perspective ( Prof Andrea Biondi - University of Milano-Bicocca, Milan, Italy )
12 Nov 2021
Latest in Philadelphia chromosome-positive ALL (Ph+ ALL)
Prof Robin Foà - Sapienza University of Rome, Rome, Italy
Latest in Philadelphia chromosome-positive ALL (Ph+ ALL) ( Prof Robin Foà - Sapienza University of Rome, Rome, Italy )
11 Nov 2021
Optimal use of asparaginase for acute lymphoblastic leukaemia
Dr Ibrahim Aldoss - City of Hope, Duarte, USA
Optimal use of asparaginase for acute lymphoblastic leukaemia ( Dr Ibrahim Aldoss - City of Hope, Duarte, USA )
10 Nov 2021
Managing immune-related adverse effects in Africa
Dr Mohammed Ezzi- University of Nairobi, Nairobi, Kenya
Managing immune-related adverse effects in Africa ( Dr Mohammed Ezzi- University of Nairobi, Nairobi, Kenya )
10 Nov 2021
Palliative care in Africa
Dr Christian Ntizimira Ruchaho - Rwanda Palliative and Hospice Organisation...
Palliative care in Africa ( Dr Christian Ntizimira Ruchaho - Rwanda Palliative and Hospice Organisation, Kigali City, Rwanda )
8 Nov 2021
Managing high-risk/MRD positive and standard-risk/MRD myeloma
Dr Stefania Oliva - GIMEMA, European Myeloma Network, Italy
Managing high-risk/MRD positive and standard-risk/MRD myeloma ( Dr Stefania Oliva - GIMEMA, European Myeloma Network, Italy )
29 Oct 2021
Minimum residual disease techniques in myeloma
Dr Stefania Oliva - GIMEMA, European Myeloma Network, Italy
Minimum residual disease techniques in myeloma ( Dr Stefania Oliva - GIMEMA, European Myeloma Network, Italy )
29 Oct 2021
AORTIC 2021: What to look out for
Dr Dorothy Lombe - Regional Cancer Treatment Service, Palmerston North, New...
AORTIC 2021: What to look out for ( Dr Dorothy Lombe - Regional Cancer Treatment Service, Palmerston North, New Zealand )
28 Oct 2021
OncoAlert and ecancer weekly round up for October 18th - October 23rd, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly round up for October 18th - October 23rd, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
26 Oct 2021

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation